Network News

X My Profile
View More Activity
Column Archive |  On Twitter: J Huget and MisFits  |  Fitness & Nutrition News  |  RSS Feeds RSS Feed

FDA cracks down on experimental autism therapy

Federal health officials are cracking down on a controversial therapy that has been promoted as an alternative for a variety of conditions, including autism, Alzheimer's disease and Parkinson's disease.

The Food and Drug Administration warned eight companies Thursday that their over-the-counter products used for a procedure known as "chelation" are "unapproved drugs and devices" and so are in "violation of federal law."

"The companies that received the warning letters claim that their products treat a range of diseases by removing toxic metals from the body. Some also claim to treat autism spectrum disorder, cardiovascular diseases, Parkinson's disease, Alzheimer's disease, macular degeneration and other serious conditions," the agency said. "Some companies that received the warning letters also claim their products will detect the presence of heavy metals to justify the need for chelation therapy."

The drugs involved have not been evaluated by the FDA for treatment of these diseases, and therefore violate the Federal Food, Drug and Cosmetic Act, the FDA said.


Eight-year-old Charlie Blakey, who was diagnosed with autism at age 3, eats dinner at his home on Oak Park, Ill., on April 23, 2008. Charlie's mother, Christina, used an alternative treatment, chelation, along with a variety of other therapies to treat her son in 2008. Chelation helps the body excrete heavy metals and is approved to treat lead poisoning in children. Charlie ate a special diet, swallowed chelation pills and has had 40 sessions in a hyperbaric chamber. All have been helpful, according to his mom in 2008. (AP)

"Despite the claims of the companies that received warning letters, the effectiveness in treating any of the diseases listed is unsubstantiated. Depending on the condition, when relying on unproven OTC chelation products to treat serious conditions, patients may delay seeking effective medical care," the FDA said.

The drug can have serious safety risks, the agency said, because the agents can "alter the levels of certain substances in the blood. Even when used under medical supervision, these products can cause serious harm, including dehydration, kidney failure, and death," the FDA said.

"These products are dangerously misleading because they are targeted to patients with serious conditions and limited treatment options," said Deborah Autor, director of the FDA's office of compliance in center for drug Evaluation and research. "The FDA must take a firm stand against companies who prey on the vulnerability of patients seeking hope and relief."

The agency advised consumers to avoid non-prescription products offered for chelation or detoxification. The only FDA-approved chelating agents are available only by prescription and approved for use in specific indications such as lead poisoning and iron overload.

The FDA took the action after noticing "an increase in 'chelation therapy' products marketed on the Internet that claim to cleanse the body of toxic chemicals and heavy metals. Although some of the products are marketed as dietary supplements, they are unapproved drugs because they claim to treat, mitigate, prevent, or diagnose disease," the FDA said. "The products come in various dosage forms, including transmucosal sprays, suppositories, capsules, liquid drops, and clay baths."

"FDA will seek enforcement action against companies that promote therapeutic benefits of products not yet evaluated by the agency for safety and effectiveness," said Dara A. Corrigan, associate commissioner for regulatory affairs.

The companies that received the warning letters are:

-- World Health Products, LLC
-- Hormonal Health, LLC and World Health Products, LLC
-- Evenbetternow, LLC
-- Maxam Nutraceutics/Maxam Laboratories
-- Cardio Renew, Inc.
-- Artery Health Institute, LLC
-- Dr. Rhonda Henry

The 2007 National Health Interview Survey, conducted by the Centers for Disease Control and Prevention, found that 111,000 adults 18 and older used chelation therapy in the previous 12 months.

The National Institutes of Health is sponsoring a large study to test whether the chelation agent EDTA is safe and effective for people 50 and over with heart disease. EDTA stands for ethylene diamine tetra-acetic acid, which is a synthetic amino acid that is delivered intravenously. The treatment is not approved for heart disease, but some doctors are using it. The results are expected in 2012.

The theory is that EDTA chelation might work by directly removing calcium found in fatty plaques that block arteries, causing the plaques to break up, that the process may stimulate the release of a hormone that in turn causes calcium to be removed from the plaques or causes a lowering of cholesterol levels. Another theory is it may reduce the damaging effects of oxygen ions (oxidative stress) on the walls of the blood vessels. Reducing oxidative stress could reduce inflammation in the arteries and improve blood vessel function. None of these theories has been well tested in scientific studies.

By Rob Stein  | October 14, 2010; 1:09 PM ET
Categories:  Alternative and Complementary Medicine, Autism, Cardiovascular Health, FDA, Kids' health, Popular Procedures  
Save & Share:  Send E-mail   Facebook   Twitter   Digg   Yahoo Buzz   Del.icio.us   StumbleUpon   Technorati   Google Buzz   Previous: Is your on-line health data safe?
Next: FDA admits mistake with knee device

Comments

EDTA is a valuable drug for heavy metal poisoning and is probably the mainstay of the treatment of lead poisoning. It is not, however, a benign drug. From the American Society of Hospital Pharmacists, "The principal and most serious toxic effect of edetate calcium disodium is renal tubular necrosis, which tends to occur when the daily dose is excessive and may result in fatal nephrosis....(referring to the injection) Anorexia, nausea, vomiting, cheilosis, tremors, headache, numbness, tingling, myalgia, arthralgia, rash, hypercalcemia, cardiac rhythm irregularities, hypotension, transient bone marrow depression, anemia, zinc deficiency, and hypercalcemia may occur...Because edetate calcium disodium is capable of producing toxic and potentially fatal effects, the recommended dosage regimens should be followed and the recommended daily dose should not be exceeded."

In a medical context, it would be most unwise to start chelating drugs without checking kidney and other functions. Where a life-threatening poisoning is present, the dose could be adjusted.

Is this really something to have over the counter, and without the ability to have laboratory monitoring? Unfortunately, consumers aren't always careful not to exceed recommended doses.

I have yet to see any statistically convincing studies that show a clear cause of autism.

Posted by: HCBerkowitz | October 16, 2010 7:43 PM | Report abuse

Post a Comment

We encourage users to analyze, comment on and even challenge washingtonpost.com's articles, blogs, reviews and multimedia features.

User reviews and comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions.




characters remaining

 
 
RSS Feed
Subscribe to The Post

© 2010 The Washington Post Company